Sonoma Pharmaceuticals, Inc. ( SNOA) - Key Metrics
SNOA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | ? | ? | ? | ? |
| 2026Q3 | ? | ? | ? | ? |
| 2026Q2 | $3.40 | -$0.32 | -$0.06 | -$0.09 |
| 2026Q1 | $2.45 | -$0.76 | -$1.23 | -$1.29 |
| 2025Q4 | $3.02 | -$0.63 | $0.46 | $0.45 |
SNOA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | ? | ? |
| 2026Q3 | ? | ? |
| 2026Q2 | ? | -2.99 |
| 2026Q1 | ? | -0.94 |
| 2025Q4 | ? | -0.88 |
SNOA
Price: $1.16
52 week price:
Earnings Per Share: -1.89 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 313242
Ebitda: -12.7 millionMarket Capitalization: 5.6 million